Share Price and Basic Stock Data
Last Updated: November 22, 2024, 11:18 pm
PEG Ratio | -1.89 |
---|
Competitors of Tata Chemicals Ltd
Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
---|---|---|---|---|---|---|---|---|---|
Caprolactam Chemicals Ltd | 24.3 Cr. | 52.8 | 64.8/43.0 | 11.6 | 0.00 % | 6.86 % | 3.67 % | 10.0 | |
Standard Industries Ltd | 170 Cr. | 26.4 | 39.0/20.2 | 43.4 | 20.1 | 3.97 % | 6.83 % | 6.28 % | 5.00 |
Gujarat Alkalies & Chemicals Ltd | 5,581 Cr. | 760 | 900/645 | 842 | 0.00 % | 3.83 % | 3.88 % | 10.0 | |
Tata Chemicals Ltd | 27,275 Cr. | 1,070 | 1,350/933 | 44.5 | 871 | 1.40 % | 7.81 % | 2.32 % | 10.0 |
Chemfab Alkalis Ltd | 1,326 Cr. | 927 | 1,230/351 | 60.3 | 279 | 0.13 % | 11.2 % | 7.88 % | 10.0 |
Industry Average | 8,588.00 Cr | 567.24 | 49.40 | 404.74 | 1.10% | 7.31% | 4.81% | 9.00 |
Quarterly Result
Month | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 2,606 | 2,636 | 2,978 | 3,023 | 3,141 | 3,481 | 3,995 | 4,239 | 4,148 | 4,407 | 4,218 | 3,998 | 3,730 |
Expenses | 2,134 | 2,353 | 2,377 | 2,522 | 2,595 | 2,824 | 2,980 | 3,319 | 3,317 | 3,442 | 3,175 | 3,191 | 3,188 |
Operating Profit | 472 | 283 | 601 | 501 | 546 | 657 | 1,015 | 920 | 831 | 965 | 1,043 | 807 | 542 |
OPM % | 18% | 11% | 20% | 17% | 17% | 19% | 25% | 22% | 20% | 22% | 25% | 20% | 15% |
Other Income | 49 | 74 | 105 | 123 | 143 | 105 | 71 | 102 | 30 | 86 | 67 | 187 | 98 |
Interest | 81 | 85 | 81 | 84 | 69 | 69 | 80 | 86 | 107 | 133 | 123 | 145 | 132 |
Depreciation | 185 | 192 | 197 | 200 | 204 | 205 | 213 | 218 | 227 | 234 | 229 | 234 | 246 |
Profit before tax | 255 | 80 | 428 | 340 | 416 | 488 | 793 | 718 | 527 | 684 | 758 | 615 | 262 |
Tax % | 21% | 64% | 20% | 21% | 16% | 9% | 20% | 5% | 19% | -1% | 23% | 20% | 26% |
Net Profit | 201 | 29 | 342 | 268 | 350 | 445 | 637 | 680 | 425 | 692 | 587 | 495 | 194 |
EPS in Rs | 6.31 | 0.46 | 11.30 | 8.68 | 12.21 | 17.19 | 23.12 | 24.65 | 15.35 | 27.83 | 20.88 | 16.80 | 6.20 |
Last Updated: Unknown
Profit & Loss - Annual Report
Last Updated: Unknown
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 13,815 | 14,711 | 15,885 | 17,204 | 14,873 | 10,346 | 10,270 | 10,337 | 10,357 | 10,200 | 12,622 | 16,789 | 16,353 |
Expenses | 11,514 | 13,096 | 15,200 | 15,305 | 12,777 | 8,249 | 6,926 | 8,538 | 8,411 | 8,693 | 10,317 | 12,969 | 12,996 |
Operating Profit | 2,301 | 1,615 | 686 | 1,900 | 2,096 | 2,097 | 3,344 | 1,799 | 1,945 | 1,506 | 2,305 | 3,820 | 3,357 |
OPM % | 17% | 11% | 4% | 11% | 14% | 20% | 33% | 17% | 19% | 15% | 18% | 23% | 21% |
Other Income | 18 | 296 | -154 | 183 | 210 | 293 | 262 | 785 | 6,480 | 254 | 486 | 218 | 438 |
Interest | 427 | 464 | 579 | 461 | 525 | 297 | 326 | 354 | 342 | 367 | 303 | 406 | 533 |
Depreciation | 509 | 534 | 471 | 463 | 526 | 512 | 518 | 568 | 666 | 759 | 806 | 892 | 943 |
Profit before tax | 1,383 | 913 | -519 | 1,159 | 1,255 | 1,580 | 2,763 | 1,661 | 7,416 | 634 | 1,682 | 2,740 | 2,319 |
Tax % | 25% | 33% | -56% | 30% | 20% | 22% | 2% | 17% | 3% | 31% | 16% | 11% | |
Net Profit | 1,037 | 607 | -811 | 802 | 1,006 | 1,234 | 2,702 | 1,387 | 7,228 | 436 | 1,405 | 2,434 | 1,968 |
EPS in Rs | 32.87 | 15.71 | -40.50 | 23.41 | 30.24 | 38.98 | 95.49 | 45.37 | 274.97 | 10.06 | 49.37 | 90.93 | 71.71 |
Dividend Payout % | 30% | 64% | -25% | 53% | 33% | 28% | 23% | 28% | 4% | 99% | 25% | 19% |
YoY Net Profit Growth
Year | 2012-2013 | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -41.47% | -233.61% | 198.89% | 25.44% | 22.66% | 118.96% | -48.67% | 421.12% | -93.97% | 222.25% | 73.24% |
Change in YoY Net Profit Growth (%) | 0.00% | -192.14% | 432.50% | -173.45% | -2.77% | 96.30% | -167.63% | 469.79% | -515.09% | 316.22% | -149.01% |
Tata Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2012-2013 to 2022-2023.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 8% |
3 Years: | 15% |
TTM: | -11% |
Compounded Profit Growth | |
---|---|
10 Years: | 10% |
5 Years: | -13% |
3 Years: | 27% |
TTM: | -69% |
Stock Price CAGR | |
---|---|
10 Years: | 19% |
5 Years: | 29% |
3 Years: | 6% |
1 Year: | 11% |
Return on Equity | |
---|---|
10 Years: | 14% |
5 Years: | 13% |
3 Years: | 7% |
Last Year: | 2% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 15, 2024, 12:32 am
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 |
Reserves | 6,159 | 5,311 | 5,297 | 6,600 | 7,653 | 10,847 | 12,086 | 12,643 | 14,035 | 17,998 | 19,466 | 21,986 | 21,940 |
Borrowings | 8,384 | 8,393 | 8,379 | 9,090 | 7,072 | 6,108 | 6,130 | 7,702 | 6,933 | 7,024 | 6,296 | 5,563 | 6,479 |
Other Liabilities | 5,288 | 6,127 | 6,872 | 8,402 | 8,607 | 8,648 | 8,398 | 7,073 | 7,115 | 8,566 | 8,923 | 8,907 | 8,947 |
Total Liabilities | 20,086 | 20,086 | 20,802 | 24,346 | 23,587 | 25,858 | 26,869 | 27,673 | 28,337 | 33,843 | 34,940 | 36,711 | 37,621 |
Fixed Assets | 10,706 | 11,007 | 11,359 | 13,280 | 12,644 | 12,787 | 13,551 | 15,356 | 15,261 | 16,044 | 17,092 | 17,861 | 18,634 |
CWIP | 592 | 468 | 189 | 350 | 333 | 409 | 774 | 835 | 1,094 | 1,668 | 2,410 | 2,217 | 2,120 |
Investments | 600 | 441 | 443 | 2,188 | 2,787 | 2,840 | 5,615 | 4,285 | 5,816 | 7,683 | 7,448 | 9,739 | 9,916 |
Other Assets | 8,189 | 8,171 | 8,811 | 8,528 | 7,822 | 9,822 | 6,929 | 7,198 | 6,167 | 8,448 | 7,990 | 6,894 | 6,951 |
Total Assets | 20,086 | 20,086 | 20,802 | 24,346 | 23,587 | 25,858 | 26,869 | 27,673 | 28,337 | 33,843 | 34,940 | 36,711 | 37,621 |
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | 2.00 | -7.00 | 678.00 | -7.00 | -7.00 | -5.00 | -3.00 | -5.00 | -6.00 | -5.00 | -5.00 | -3.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 85 | 74 | 73 | 88 | 74 | 46 | 51 | 56 | 50 | 56 | 57 | 45 |
Inventory Days | 101 | 96 | 137 | 119 | 244 | 304 | 315 | 347 | 257 | 318 | 282 | 341 |
Days Payable | 133 | 119 | 138 | 99 | 232 | 307 | 269 | 302 | 256 | 338 | 289 | 320 |
Cash Conversion Cycle | 53 | 52 | 72 | 107 | 86 | 43 | 97 | 100 | 51 | 35 | 50 | 66 |
Working Capital Days | 23 | 45 | 23 | 75 | 21 | 32 | 11 | -35 | 27 | 63 | 42 | 31 |
ROCE % | 10% | 3% | 11% | 11% | 10% | 16% | 9% | 36% | 4% | 8% | 12% | 8% |
Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
---|---|---|---|---|---|---|
HDFC Mid-Cap Opportunities Fund - Regular Plan | 4,260,000 | 0.74 | 437.95 | 508,000 | 2024-11-21 | 738.58% |
Kotak Flexicap Fund - Regular Plan | 3,750,000 | 0.87 | 385.52 | 508,000 | 2024-11-21 | 638.19% |
Kotak Equity Opportunities Fund - Regular Plan | 2,064,884 | 1.16 | 212.28 | 508,000 | 2024-11-21 | 306.47% |
Nippon India Growth Fund | 1,561,427 | 0.66 | 160.52 | 508,000 | 2024-11-21 | 207.37% |
DSP Mid Cap Fund | 1,382,053 | 0.86 | 142.08 | 508,000 | 2024-11-21 | 172.06% |
DSP Equity Opportunities Fund | 717,459 | 0.69 | 73.76 | 508,000 | 2024-11-21 | 41.23% |
HDFC Large and Mid Cap Fund - Regular Plan | 508,000 | 0.33 | 52.22 | 508,000 | 2024-11-21 | 0% |
Quant Active Fund | 217,000 | 0.27 | 22.31 | 508,000 | 2024-11-21 | -57.28% |
Edelweiss Arbitrage Fund | 149,600 | 0.19 | 15.38 | 508,000 | 2024-11-21 | -70.55% |
Kotak Multicap Fund | 143,500 | 0.17 | 14.75 | 508,000 | 2024-11-21 | -71.75% |
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 10.52 | 90.95 | 49.37 | 10.06 | 275.02 |
Diluted EPS (Rs.) | 10.52 | 90.95 | 49.37 | 10.06 | 275.02 |
Cash EPS (Rs.) | 52.82 | 130.43 | 77.91 | 45.91 | 309.96 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 906.43 | 809.49 | 751.80 | 594.25 | 536.12 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 906.43 | 809.49 | 751.80 | 594.25 | 536.12 |
Revenue From Operations / Share (Rs.) | 604.75 | 658.39 | 495.33 | 400.27 | 406.43 |
PBDIT / Share (Rs.) | 122.86 | 158.43 | 100.49 | 68.09 | 88.70 |
PBIT / Share (Rs.) | 84.43 | 123.45 | 68.85 | 38.29 | 62.55 |
PBT / Share (Rs.) | 29.88 | 107.45 | 56.53 | 23.87 | 49.13 |
Net Profit / Share (Rs.) | 14.39 | 95.45 | 46.27 | 16.11 | 283.81 |
NP After MI And SOA / Share (Rs.) | 10.51 | 90.86 | 49.35 | 10.06 | 274.95 |
PBDIT Margin (%) | 20.31 | 24.06 | 20.28 | 17.01 | 21.82 |
PBIT Margin (%) | 13.96 | 18.75 | 13.90 | 9.56 | 15.38 |
PBT Margin (%) | 4.94 | 16.32 | 11.41 | 5.96 | 12.08 |
Net Profit Margin (%) | 2.37 | 14.49 | 9.34 | 4.02 | 69.82 |
NP After MI And SOA Margin (%) | 1.73 | 13.80 | 9.96 | 2.51 | 67.64 |
Return on Networth / Equity (%) | 1.20 | 11.74 | 6.88 | 1.79 | 54.32 |
Return on Capital Employeed (%) | 7.01 | 10.43 | 6.55 | 4.08 | 7.71 |
Return On Assets (%) | 0.72 | 6.60 | 3.71 | 0.90 | 25.30 |
Long Term Debt / Equity (X) | 0.13 | 0.28 | 0.20 | 0.36 | 0.26 |
Total Debt / Equity (X) | 0.22 | 0.30 | 0.37 | 0.38 | 0.41 |
Asset Turnover Ratio (%) | 0.42 | 0.48 | 0.40 | 0.14 | 0.14 |
Current Ratio (X) | 1.05 | 1.66 | 1.23 | 1.49 | 1.11 |
Quick Ratio (X) | 0.63 | 1.15 | 0.90 | 1.11 | 0.84 |
Inventory Turnover Ratio (X) | 1.07 | 1.22 | 1.22 | 0.50 | 0.44 |
Dividend Payout Ratio (NP) (%) | 166.41 | 13.72 | 20.25 | 109.30 | 5.47 |
Dividend Payout Ratio (CP) (%) | 35.73 | 9.90 | 12.34 | 27.59 | 5.00 |
Earning Retention Ratio (%) | -66.41 | 86.28 | 79.75 | -9.30 | 94.53 |
Cash Earning Retention Ratio (%) | 64.27 | 90.10 | 87.66 | 72.41 | 95.00 |
Interest Coverage Ratio (X) | 5.91 | 9.95 | 8.46 | 4.72 | 6.61 |
Interest Coverage Ratio (Post Tax) (X) | 3.34 | 7.04 | 4.91 | 2.12 | 4.02 |
Enterprise Value (Cr.) | 32847.30 | 31130.10 | 31228.96 | 24062.00 | 9753.04 |
EV / Net Operating Revenue (X) | 2.13 | 1.85 | 2.47 | 2.36 | 0.94 |
EV / EBITDA (X) | 10.48 | 7.71 | 12.20 | 13.87 | 4.31 |
MarketCap / Net Operating Revenue (X) | 1.79 | 1.48 | 1.97 | 1.88 | 0.54 |
Retention Ratios (%) | -66.41 | 86.27 | 79.74 | -9.30 | 94.52 |
Price / BV (X) | 1.24 | 1.26 | 1.36 | 1.34 | 0.44 |
Price / Net Operating Revenue (X) | 1.79 | 1.48 | 1.97 | 1.88 | 0.54 |
EarningsYield | 0.01 | 0.09 | 0.05 | 0.01 | 1.23 |
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Tata Chemicals Ltd:
- Net Profit Margin: 2.37%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 7.01% (Industry Average ROCE: 7.31%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.2% (Industry Average ROE: 4.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 44.5 (Industry average Stock P/E: 49.4)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.22
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.37%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Chemicals - Inorganic - Caustic Soda/Soda Ash | Bombay House, 24, Homi Mody Street, Mumbai Maharashtra 400001 | investors@tatachemicals.com http://www.tatachemicals.com |
Management | |
---|---|
Name | Position Held |
Mr. Ratan N Tata | Chairman Emeritus |
Mr. N Chandrasekaran | Chairman |
Mr. R Mukundan | Managing Director & CEO |
Mr. S Padmanabhan | Non Exe.Non Ind.Director |
Mr. Rajiv Dube | Ind. Non-Executive Director |
Dr. C V Natraj | Ind. Non-Executive Director |
Mr. K B S Anand | Ind. Non-Executive Director |
Ms. Vibha Paul Rishi | Ind. Non-Executive Director |
Mrs. Padmini Khare Kaicker | Ind. Non-Executive Director |
FAQ
What is the latest intrinsic value of Tata Chemicals Ltd?
The latest intrinsic value of Tata Chemicals Ltd as on 22 November 2024 is ₹911.81, which is 14.78% lower than the current market price of ₹1,070.00.
What is the Market Cap of Tata Chemicals Ltd?
The Market Cap of Tata Chemicals Ltd is 27,275 Cr..
What is the current Stock Price of Tata Chemicals Ltd as on 22 November 2024?
The current stock price of Tata Chemicals Ltd as on 22 November 2024 is 1,070.
What is the High / Low of Tata Chemicals Ltd stocks in FY 2024?
In FY 2024, the High / Low of Tata Chemicals Ltd stocks is 1,350/933.
What is the Stock P/E of Tata Chemicals Ltd?
The Stock P/E of Tata Chemicals Ltd is 44.5.
What is the Book Value of Tata Chemicals Ltd?
The Book Value of Tata Chemicals Ltd is 871.
What is the Dividend Yield of Tata Chemicals Ltd?
The Dividend Yield of Tata Chemicals Ltd is 1.40 %.
What is the ROCE of Tata Chemicals Ltd?
The ROCE of Tata Chemicals Ltd is 7.81 %.
What is the ROE of Tata Chemicals Ltd?
The ROE of Tata Chemicals Ltd is 2.32 %.
What is the Face Value of Tata Chemicals Ltd?
The Face Value of Tata Chemicals Ltd is 10.0.